SMALL CAP IDEA: 'Neuro-psych' specialist Solvonis emerges in takeover wave
In the world of life sciences, deal flow often serves as a barometer for emerging trends.The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, highlight the growing interest in mental health treatment.This...